Quick Answer
Axsome Therapeutics, Inc. reported Total Assets of $689.80 million for fiscal year 2025.
Axsome Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $689.80M | +21.3% |
| 2024 | $568.50M | -3.4% |
| 2023 | $588.24M | +77.5% |
| 2022 | $331.48M | +277.6% |
| 2021 | $87.79M | -52.8% |
| 2020 | $186.13M | -15.6% |
| 2019 | $220.55M | +1334.1% |
| 2018 | $15.38M | -56.7% |
| 2017 | $35.56M | -7.0% |
| 2016 | $38.21M | -22.1% |
| 2015 | $49.08M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $669.25M | +19.2% | +4.6% |
| June 30, 2025 | $639.78M | +16.7% | +7.2% |
| March 31, 2025 | $596.67M | +9.3% | +5.0% |
| December 31, 2024 | $568.50M | -3.4% | +1.3% |
| September 30, 2024 | $561.46M | -6.6% | +2.4% |
| June 30, 2024 | $548.23M | -10.4% | +0.5% |
| March 31, 2024 | $545.73M | +40.2% | -7.2% |
| December 31, 2023 | $588.24M | +77.5% | -2.1% |
- Axsome Therapeutics, Inc. showed an increase of +21.3% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Axsome Therapeutics, Inc.’s total assets has grown by 1305.6% (from $49.08 million to $689.80 million).
- The most recent figure is from Axsome Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: